Common Variants in the PALB2 Gene Confer Susceptibility to Breast Cancer: a Meta-analysis |
Zhang, Yi-Xia
(Department of Ultrasonography, the First Affiliated Hospital of China Medical University)
Wang, Xue-Mei (Department of Ultrasonography, the First Affiliated Hospital of China Medical University) Kang, Shu (Department of Ultrasonography, the First Affiliated Hospital of China Medical University) Li, Xiang (Department of Ultrasonography, the First Affiliated Hospital of China Medical University) Geng, Jing (Department of Ultrasonography, the First Affiliated Hospital of China Medical University) |
1 | Cao AY, Huang J, Hu Z, et al (2009). The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat, 114, 457-62. DOI |
2 | Cao AY, Yu KD, Yin WJ, et al (2010). Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population. Breast Cancer Res Treat, 123, 133-8. DOI |
3 | Casadei S, Norquist BM, Walsh T, et al (2011). Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res, 71, 2222-9. DOI |
4 | Chen P, Liang J, Wang Z, et al (2008). Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. Clin Cancer Res, 14, 5931-7. DOI ScienceOn |
5 | Colditz GA, Kaphingst KA, Hankinson SE, et al (2012). Family history and risk of breast cancer: nurses' health study. Breast Cancer Res Treat, 133, 1097-104. DOI |
6 | Dupont WD and Plummer WD, Jr. (1990). Power and sample size calculations. A review and computer program. Control Clin Trials, 11, 116-28. DOI ScienceOn |
7 | Eeles RA, Olama AA, Benlloch S, et al (2013). Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet, 45, 385-91, 91e1-2. |
8 | Erkko H, Xia B, Nikkila J, et al (2007). A recurrent mutation in PALB2 in Finnish cancer families. Nature, 446, 316-9. DOI ScienceOn |
9 | Frankenberg-Schwager M and Gregus A (2012). Chromosomal instability induced by mammography X-rays in primary human fibroblasts from BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol, 88, 846-57. DOI ScienceOn |
10 | Guenard F, Pedneault CS, Ouellette G, et al (2010). Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer. Genet Test Mol Biomarkers, 14, 515-26. DOI ScienceOn |
11 | Heikkinen T, Karkkainen H, Aaltonen K, et al (2009). The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res, 15, 3214-22. DOI ScienceOn |
12 | Hellebrand H, Sutter C, Honisch E, et al (2011). Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum Mutat, 32, E2176-88. DOI ScienceOn |
13 | Jackson D, White IR and Riley RD (2012). Quantifying the impact of between-study heterogeneity in multivariate metaanalyses. Stat Med, 31, 3805-20. DOI ScienceOn |
14 | Kuusisto KM, Bebel A, Vihinen M, et al (2011). Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Breast Cancer Res, 13, R20. DOI ScienceOn |
15 | Llanos AA, Dumitrescu RG, Marian C, et al (2012). Adipokines in plasma and breast tissues: associations with breast cancer risk factors. Cancer Epidemiol Biomarkers Prev, 21, 1745-55. DOI ScienceOn |
16 | O'Donovan PJ and Livingston DM (2010). BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis, 31, 961-7. DOI ScienceOn |
17 | Pern F, Bogdanova N, Schurmann P, et al (2012). Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospitalbased series of German patients with triple-negative breast cancer. PLoS One, 7, e47993. DOI |
18 | Siaud N, Barbera MA, Egashira A, et al (2011). Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains. PLoS Genet, 7, e1002409. DOI |
19 | Peters JL, Sutton AJ, Jones DR, et al (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676-80. DOI ScienceOn |
20 | Rahman N, Seal S, Thompson D, et al (2007). PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet, 39, 165-7. DOI ScienceOn |
21 | Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5. DOI |
22 | Stephens PJ, Tarpey PS, Davies H, et al (2012). The landscape of cancer genes and mutational processes in breast cancer. Nature, 486, 400-4. |
23 | Teo ZL, Provenzano E, Dite GS, et al (2013). Tumour morphology predicts PALB2 germline mutation status. Br J Cancer, 109, 154-63. DOI ScienceOn |
24 | Xia B, Sheng Q, Nakanishi K, et al (2006). Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell, 22, 719-29. DOI ScienceOn |
25 | Zintzaras E, Ioannidis JP (2005). HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics, 21, 3672-3. DOI ScienceOn |
26 | Bogdanova N, Sokolenko AP, Iyevleva AG, et al (2011). PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat, 126, 545-50. DOI |
27 | Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801. DOI ScienceOn |
28 | Benson JR, Jatoi I (2012). The global breast cancer burden. Future Oncol, 8, 697-702. DOI |
![]() |